AFP and hepatocellular carcinoma: In the present study, we investigated the relationship between the early clinical response in intra-tumor blood flow on CE-CT, AFP levels and remnant liver function after 2 weeks of sorafenib treatment and the outcomes and anti-tumor response in patients with advanced HCC.